Guggenheim Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Guggenheim Capital’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.31M	Buy	44,050 +6,341	+17%	+$500K	0.03%	554
2025 Q4	$2.98M	Buy	37,709 +2,352	+7%	+$177K	0.02%	565
2025 Q3	$2.31M	Sell	35,357 -5,500	-13%	-$269K	0.02%	647
2025 Q2	$1.61M	Sell	40,857 -557	-1%	-$18.2K	0.01%	716
2025 Q1	$1.25M	Buy	41,414 +6,041	+17%	+$198K	0.01%	799
2024 Q4	$1.24M	Sell	35,373 -1,786	-5%	-$66.8K	0.01%	821
2024 Q3	$1.49M	Buy	37,159 +1,770	+5%	+$82.4K	0.01%	939
2024 Q2	$1.69M	Sell	35,389 -461	-1%	-$18.9K	0.01%	876
2024 Q1	$1.55M	Buy	35,850 +2,699	+8%	+$129K	0.01%	995
2023 Q4	$1.68M	Sell	33,151 -7,324	-18%	-$351K	0.01%	920
2023 Q3	$1.84M	Sell	40,475 -11,451	-22%	-$472K	0.02%	839
2023 Q2	$2.13M	Sell	51,926 -11,637	-18%	-$447K	0.02%	832
2023 Q1	$2.27M	Buy	63,563 +1,404	+2%	+$52.7K	0.02%	798
2022 Q4	$2.35M	Buy	62,159 +7,190	+13%	+$302K	0.02%	800
2022 Q3	$2.43M	Sell	54,969 -8,777	-14%	-$370K	0.02%	765
2022 Q2	$2.36M	Sell	63,746 -4,491	-7%	-$169K	0.02%	821
2022 Q1	$2.53M	Sell	68,237 -4,741	-6%	-$155K	0.02%	912
2021 Q4	$2.22M	Buy	72,978 +10,341	+17%	+$325K	0.01%	1005
2021 Q3	$2.1M	Buy	62,637 +6,501	+12%	+$245K	0.01%	1033
2021 Q2	$2.24M	Sell	56,136 -15,256	-21%	-$598K	0.01%	1034
2021 Q1	$3.21M	Buy	71,392 +10,538	+17%	+$588K	0.02%	810
2020 Q4	$3.44M	Sell	60,854 -13,367	-18%	-$666K	0.02%	742
2020 Q3	$3.52M	Sell	74,221 -4,615	-6%	-$256K	0.03%	668
2020 Q2	$4.65M	Buy	78,836 +12,946	+20%	+$720K	0.04%	541
2020 Q1	$3.12M	Sell	65,890 -14,477	-18%	-$807K	0.03%	626
2019 Q4	$4.86M	Buy	80,367 +13,025	+19%	+$776K	0.04%	643
2019 Q3	$4.03M	Sell	67,342 -3,467	-5%	-$226K	0.03%	690
2019 Q2	$4.55M	Sell	70,809 -1,937	-3%	-$137K	0.04%	659
2019 Q1	$5.91M	Sell	72,746 -11,092	-13%	-$716K	0.05%	523
2018 Q4	$4.53M	Sell	83,838 -12,479	-13%	-$636K	0.04%	621
2018 Q3	$4.97M	Buy	96,317 +550	+0.6%	+$25.8K	0.03%	727
2018 Q2	$3.99M	Buy	95,767 +4,485	+5%	+$199K	0.03%	855
2018 Q1	$4.02M	Buy	91,282 +1,893	+2%	+$96.2K	0.01%	1145
2017 Q4	$4.5M	Sell	89,389 -13,366	-13%	-$733K	0.01%	1097
2017 Q3	$5.21M	Buy	102,755 +4,316	+4%	+$226K	0.01%	1040
2017 Q2	$5.01M	Sell	98,439 -18,716	-16%	-$872K	0.01%	1012
2017 Q1	$4.71M	Buy	117,155 +21,426	+22%	+$962K	0.01%	1060
2016 Q4	$4.58M	Sell	95,729 -42,837	-31%	-$1.7M	0.01%	1057
2016 Q3	$5.08M	Sell	138,566 -8,471	-6%	-$265K	0.02%	1007
2016 Q2	$3.42M	Buy	147,037 +20,359	+16%	+$657K	0.01%	1216
2016 Q1	$5.13M	Sell	126,678 -28,962	-19%	-$1.18M	0.02%	975
2015 Q4	$9.64M	Sell	155,640 -76,943	-33%	-$4.15M	0.03%	762
2015 Q3	$9.4M	Sell	232,583 -20,154	-8%	-$1.04M	0.03%	778
2015 Q2	$14.5M	Buy	252,737 +49,362	+24%	+$3.14M	0.04%	702
2015 Q1	$12.9M	Buy	203,375 +15,736	+8%	+$1.07M	0.03%	757
2014 Q4	$11.6M	Buy	187,639 +15,067	+9%	+$743K	0.03%	778
2014 Q3	$6.7M	Sell	172,572 -11,767	-6%	-$417K	0.02%	1066
2014 Q2	$6.35M	Sell	184,339 -12,266	-6%	-$386K	0.02%	1058
2014 Q1	$8.5M	Buy	196,605 +18,742	+11%	+$908K	0.02%	902
2013 Q4	$7.09M	Buy	177,863 +3,957	+2%	+$141K	0.02%	942
2013 Q3	$6.53M	Sell	173,906 -15,984	-8%	-$477K	0.02%	973
2013 Q2	$5.1M	Buy	+189,890	New	+$4.04M	0.02%	1043